Funding agencies: This work was supported by the National Reference Center for Huntington's Disease (Ministry of Health, France) and by a Contrat d'Interface INSERM (A.-C.B.-L.). Additional support was provided through the NeurATRIS (European Advanced Translational Research Infrastructure in Neurosciences) Project, the Groupement d'Intérêt Scientifique (GIS)-Institut des Maladies Rares, and the “Biomarker Program” AP-HP.
The unified huntington's disease rating scale for advanced patients: Validation and follow-up study
Version of Record online: 9 OCT 2013
© 2013 Movement Disorder Society
Volume 28, Issue 14, pages 1995–2001, December 2013
How to Cite
Youssov, K., Dolbeau, G., Maison, P., Boissé, M.-F., de Langavant, L. C., Roos, R. A. C. and Bachoud-Lévi, A.-C. (2013), The unified huntington's disease rating scale for advanced patients: Validation and follow-up study. Mov. Disord., 28: 1995–2001. doi: 10.1002/mds.25678
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 9 DEC 2013
- Version of Record online: 9 OCT 2013
- Manuscript Accepted: 16 AUG 2013
- Manuscript Received: 13 JUL 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.